Cardiac Resynchronisation Therapy In Patients With Heart Failure: Mechanistic Insights From Cardiac MRI And Electroanatomical Mapping
- Conditions
- Heart Failure
- Interventions
- Procedure: Temporary pacing StudyRadiation: Thoracic CTDiagnostic Test: Acute hemodynamic studyDiagnostic Test: Invasive catheter-based mappingDiagnostic Test: Non-invasive body surface mapping
- Registration Number
- NCT04322877
- Lead Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Brief Summary
Cardiac Resynchronisation Therapy (CRT) is a specialist pacemaker procedure that aims to improve the efficiency of the heartbeat. This treatment is used routinely in patients with heart failure and a delay in electrical conduction across the heart seen on the surface ECG (heart tracing). The investigators aim to assess acute response to CRT and compare different methods of delivering CRT using hemodynamic data from invasive dP/dTmax and electroanatomical data from either invasive mapping or non-invasive body surface mapping.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Either 1) has CRT system in situ or 2) has a planned CRT system implant or 3) has a planned upgrade to CRT from a standard pacemaker
- NYHA grade II-IV heart failure
- LVEF<35%
- Intrinsic QRS duration >120ms
- On optimum medical therapy for heart failure
- Female participants of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study and for 3 months thereafter
- Able (in the Investigators opinion) and willing to comply with all study requirements.
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study.
- Female participants who is pregnant, lactating or planning pregnancy during the course of the study.
- Scheduled elective surgery or other procedures requiring general anaesthesia during the study.
- Participant who is terminally ill or is inappropriate for placebo medication
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
- Rate uncontrolled atrial fibrillation precluding a cMR
- Significant peripheral vascular disease precluding an EP study
- A contraindication to anticoagulation
- A prosthetic aortic or tricuspid valve
- Significant Aortic valve disease
- Known LV thrombus
- Insufficient capacity to consent to the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Body surface mapping and temporary pacing Thoracic CT Temporary pacing procedure with acute hemodynamic study and non-invasive body surface mapping. Catheter-based mapping and temporary pacing Acute hemodynamic study Temporary pacing procedure with acute hemodynamic study and invasive catheter-based mapping. Catheter-based mapping and temporary pacing Invasive catheter-based mapping Temporary pacing procedure with acute hemodynamic study and invasive catheter-based mapping. Body surface mapping and temporary pacing Acute hemodynamic study Temporary pacing procedure with acute hemodynamic study and non-invasive body surface mapping. Body surface mapping and temporary pacing Non-invasive body surface mapping Temporary pacing procedure with acute hemodynamic study and non-invasive body surface mapping. Body surface mapping and temporary pacing Temporary pacing Study Temporary pacing procedure with acute hemodynamic study and non-invasive body surface mapping. Catheter-based mapping and temporary pacing Temporary pacing Study Temporary pacing procedure with acute hemodynamic study and invasive catheter-based mapping.
- Primary Outcome Measures
Name Time Method Improvement in LV dP/dTmax >10 percent during temporary multisite pacing Intra-procedure
- Secondary Outcome Measures
Name Time Method Electrical dyssynchrony measured from electro-anatomical mapping Intra-procedure
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Guys and St Thomas' NHS Foundation Trust
🇬🇧London, United Kingdom